We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Lyophilized Control Monitors Precision of Tumor Marker Testing

By LabMedica International staff writers
Posted on 12 Feb 2009
A lyophilized quality control based on human serum, monitors the precision of tumor marker testing procedures.

The Lyphochek tumor marker plus control includes high target levels of cancer antigens and ferritin, as well as a very low level of prostate-specific antigen (PSA). It has a three-year shelf life when stored at 2-8 ºC. Its reconstituted stability is 14 days at 2-8 ºC and 30 days at -20-70 °C (for most analytes).

Assayed values are provided for manual and automated test methods. The Unity Interlaboratory Program with peer group comparison is available for use with the Lyphochek tumor marker plus control. The Unity Interlaboratory Program is an expert data management software system designed to improve the effectiveness of quality control processes.

Launched by Bio-Rad Laboratories, (Hercules, CA, USA), a multinational manufacturer and distributor of clinical diagnostic products, the Lyphochek multianalyte control features 23 tumor markers. Being a blood-based material, the control can be processed in the same manner as patient samples, ensuring quality on an ongoing basis.

Bio-Rad products are used worldwide by laboratories, hospitals, universities, major research institutions, as well as biotechnology and pharmaceutic companies.

Related Links:

Bio-Rad Laboratories




Gold Member
Turnkey Packaging Solution
HLX
Automated Blood Typing System
IH-500 NEXT
New
Auto-Chemistry Analyzer
CS-1200
New
Lab Sample Rotator
H5600 Revolver

Latest Immunology News

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

Computational Tool Predicts Immunotherapy Outcomes for Metastatic Breast Cancer Patients